Cisplatin-Epinephrine Injectable Gel Plus Paclitaxel and Carboplatin in Treating Patients With Recurrent Head and Neck Cancer
Clinical trial NCT00022217 · UNKNOWN
Trial details
- NCT number
- NCT00022217
- Sponsor
- Matrix Pharmaceutical
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2000-11-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.